E-Commerce is fastest growing segment fueling the growth of Infectious Disease Therapeutics Market

 

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi. Infectious disease therapeutics includes antibiotics, antivirals and antifungals that aid in effective treatment of various infectious diseases. With rising prevalence of infectious diseases and antibiotic resistance, the need for development of novel drugs continues to grow.

The infectious disease therapeutics market is estimated to be valued at US$ 170.67 Bn in 2023 and is expected to exhibit a CAGR of 3.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the key trends in the infectious disease therapeutics market is the rising number of pipeline drugs for treatment of resistant bacterial and viral infections. Growing antibiotic resistance has created an urgent need for development of novel antimicrobial drugs. There are currently around 50 antibiotics in phase 3 clinical trials that aim to target multi-drug resistant bacterial strains. Additionally, around 60 new molecular entities are under development to treat viral infections such as hepatitis C, herpes, HIV, influenza, among others. This robust drug pipeline is expected to significantly boost the market growth during the forecast period.
Segment Analysis

The global infectious disease therapeutics market is segmented on the basis of disease type, drug class, route of administration, and end user. Based on disease type, the market is segmented into bacterial disease, viral disease, fungal disease, and parasitic disease. The viral disease segment currently dominates the market and is expected to continue its dominance over the forecast period owing to the high prevalence of chronic viral diseases such as hepatitis and HIV/AIDS globally.

Key Takeaways
The global infectious disease therapeutics market is expected to witness high growth, exhibiting CAGR of 3.7% over the forecast period, due to increasing prevalence of infectious diseases worldwide.

Regional analysis
North America currently dominates the infectious disease therapeutics market due to strong presence of key players and high healthcare spending in the region. Asia Pacific is expected to register the fastest growth over the coming years due to increasing healthcare expenditure and growing patient awareness in emerging countries such as China and India.

Key players
Key players operating in the infectious disease therapeutics market are Novartis International AG, Gilead Sciences, Inc., GlaxoSmithKline plc, Janssen Pharmaceutical, F. Hoffmann-La Roche AG, BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH. among others. These players are focusing on developing innovative therapies to expand their market share.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more